Syqe Medical Ltd. THC Inhaler, 0.75mg Max
Summary
Syqe Medical Ltd. filed patent application US20260108542A1 on December 19, 2025 (application no. 19426146), published April 23, 2026, covering a THC inhaler system with a scheduled regimen that caps delivery at 0.75 mg THC or less over a minimum 2-hour period. The system includes a memory storing the regimen, a decision module that determines whether delivery should occur, and a controller in the inhaler device executing delivery based on those decisions. The named inventors include Perry Davidson, Seth Kindler, Shlomo Almog, Binyamin Schwartz, Aaron Schorr, and Daniella Atzmony.
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
Syqe Medical Ltd. filed a patent application covering a low-dose THC delivery system that stores a scheduled regimen defining a maximum of 0.75 mg THC delivered over 2 or more hours, with a decision module controlling whether doses are released and a controller executing delivery. The application is classified under CPC codes including A61K 31/658 (cannabis derivatives), A61M 15/009 (inhalers), and G16H 20/13 (digital therapeutics for drug delivery).
Patent applicants or investors in cannabis-based therapeutic delivery technology should monitor the prosecution of this application for potential licensing opportunities or competitive filings in the low-dose THC inhaler space. Pharmaceutical and medical device companies developing digital dose-delivery systems for controlled substances may find this application relevant to freedom-to-operate analyses.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
LOW DOSE THERAPEUTIC TREATMENT
Application US20260108542A1 Kind: A1 Apr 23, 2026
Assignee
Syqe Medical Ltd.
Inventors
Perry DAVIDSON, Seth KINDLER, Shlomo ALMOG, Binyamin SCHWARTZ, Aaron SCHORR, Daniella ATZMONY
Abstract
Some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of THC, the system comprising: a memory which stores a scheduled regimen for delivery of THC to the subject, the scheduled regimen defining: a maximal amount of THC to be delivered, the amount being 0.75 mg THC or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering THC to the subject, the inhaler device comprising a controller which carries out delivery of THC based on the decision made by the decision module.
CPC Classifications
A61K 31/658 A61K 9/008 A61M 11/042 A61M 15/0003 A61M 15/009 A61P 29/02 G16H 20/13 G16H 40/63 A61M 2205/52
Filing Date
2025-12-19
Application No.
19426146
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.